PAULA PIERCE-SAVOIE PA-C
Prescription History 1821528621
Physician Assistant in Carterville, IL

Active since June 14, 2017PECOS EnrolledAccepts Medicare Assignment
75.73/100
CMS Quality Rating
1400 PIN OAK DR, CARTERVILLE, IL 62918(618) 985-3333(618) 985-1318 Get Directions

NPPES record last updated: September 27, 2021. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: Sep 27, 2021, Jan 29, 2021, Nov 11, 2019 and 2 more (5 updates tracked since 2017).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for PAULA PIERCE-SAVOIE PA-C, an active Physician Assistant specialist practicing in Carterville, IL. Our medical registry currently tracks 9 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 194 documented patient claims. Among these therapy options, the most frequently utilized medication is Anastrozole, which accounts for 62 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

9
Medications
194
Total Claims
343
30-Day Fills
Anastrozole
Most Prescribed · 62 claims
View details
9 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by PAULA PIERCE-SAVOIE PA-C in 2024, with prescription volumes, average cost per fill, and IL state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other IL PrescribersVs. IL Avg

About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾

Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women.

In 2024, this provider wrote 62 Medicare prescriptions for Anastrozole, about 82% of the volume of the typical Illinois prescriber of this medication (75.6). Medicare paid an average of $18.57 per fill, versus $17.15 statewide.

How often this provider prescribes it

This provider
62
IL average
75.6

This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$18.57
IL average
$17.15

Gross Part D cost per fill; not the patient's out-of-pocket price.

170
30-Day Fills
standardized to 30-day supplies
5,098
Days of Medication
total across all patients in 2024

About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾

Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.

In 2024, this provider wrote 24 Medicare prescriptions for Hydroxyurea, about 67% of the volume of the typical Illinois prescriber of this medication (35.9). Medicare paid an average of $6.17 per fill, versus $21.27 statewide.

How often this provider prescribes it

This provider
24
IL average
35.9

This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$6.17
IL average
$21.27

This provider's average cost per fill is below the IL average for this medication.

31.3
30-Day Fills
standardized to 30-day supplies
929
Days of Medication
total across all patients in 2024

About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾

Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women.

In 2024, this provider wrote 24 Medicare prescriptions for Letrozole, about half the volume of the typical Illinois prescriber of this medication (55.6). Medicare paid an average of $21.06 per fill, versus $19.02 statewide.

How often this provider prescribes it

This provider
24
IL average
55.6

This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$21.06
IL average
$19.02

Gross Part D cost per fill; not the patient's out-of-pocket price.

58
30-Day Fills
standardized to 30-day supplies
1,715
Days of Medication
total across all patients in 2024

About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾

It works by slowing or stopping the growth of cancer cells. Has antineoplastic activity; specific inhibitor of cyclin-dependent kinases 4 & 6.

In 2024, this provider wrote 20 Medicare prescriptions for Ibrance, about 79% of the volume of the typical Illinois prescriber of this medication (25.2). Medicare paid an average of $16,512.67 per fill, versus $15,532.84 statewide.

How often this provider prescribes it

This provider
20
IL average
25.2

This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$16,512.67
IL average
$15,532.84

Gross Part D cost per fill; not the patient's out-of-pocket price.

20
30-Day Fills
standardized to 30-day supplies
560
Days of Medication
total across all patients in 2024

About Morphine Sulfate Er: This medication is used to help relieve severe ongoing pain (such as due to cancer). Show more ▾

Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (100 milligrams or more per tablet) should be used only if you have been regularly taking moderate to large amounts of opioid pain medications. These strengths may cause overdose (even death) if taken by a person who has not been regularly taking opioids. Do not use the extended-release form of morphine to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use. The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

In 2024, this provider wrote 18 Medicare prescriptions for Morphine Sulfate Er, about half the volume of the typical Illinois prescriber of this medication (36.9). Medicare paid an average of $22.66 per fill, versus $32.29 statewide.

How often this provider prescribes it

This provider
18
IL average
36.9

This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$22.66
IL average
$32.29

This provider's average cost per fill is below the IL average for this medication.

18
30-Day Fills
standardized to 30-day supplies
515
Days of Medication
total across all patients in 2024

About Hydrocodone-Acetaminophen: This combination medication is used to relieve moderate to severe pain. Show more ▾

It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

In 2024, this provider wrote 12 Medicare prescriptions for Hydrocodone-Acetaminophen, about 17% of the volume of the typical Illinois prescriber of this medication (70.6). Medicare paid an average of $16.53 per fill, versus $20.03 statewide.

How often this provider prescribes it

This provider
12
IL average
70.6

This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$16.53
IL average
$20.03

This provider's average cost per fill is below the IL average for this medication.

12
30-Day Fills
standardized to 30-day supplies
201
Days of Medication
total across all patients in 2024

About Oxycodone-Acetaminophen: This combination medication is used to help relieve moderate to severe pain. Show more ▾

It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

In 2024, this provider wrote 12 Medicare prescriptions for Oxycodone-Acetaminophen, about a quarter of the volume of the typical Illinois prescriber of this medication (46.6). Medicare paid an average of $33.62 per fill, versus $27.50 statewide.

How often this provider prescribes it

This provider
12
IL average
46.6

This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$33.62
IL average
$27.50

Gross Part D cost per fill; not the patient's out-of-pocket price.

12
30-Day Fills
standardized to 30-day supplies
250
Days of Medication
total across all patients in 2024

About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾

Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. A hormonal antineoplastic agent.

In 2024, this provider wrote 11 Medicare prescriptions for Exemestane, about a third of the volume of the typical Illinois prescriber of this medication (29.2). Medicare paid an average of $71.75 per fill, versus $174.13 statewide.

How often this provider prescribes it

This provider
11
IL average
29.2

This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$71.75
IL average
$174.13

This provider's average cost per fill is below the IL average for this medication.

11
30-Day Fills
standardized to 30-day supplies
330
Days of Medication
total across all patients in 2024

About Imbruvica: This medication is used to treat certain cancers (such as chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾

Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). A Btk protein inhibitor.

In 2024, this provider wrote 11 Medicare prescriptions for Imbruvica, about half the volume of the typical Illinois prescriber of this medication (24.8). Medicare paid an average of $16,343.66 per fill, versus $15,499.34 statewide.

How often this provider prescribes it

This provider
11
IL average
24.8

This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$16,343.66
IL average
$15,499.34

Gross Part D cost per fill; not the patient's out-of-pocket price.

11
30-Day Fills
standardized to 30-day supplies
308
Days of Medication
total across all patients in 2024
No medications match the current filters.
= the 5 medications this provider prescribes most.▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average IL prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the IL average cost per fill.

About this data. The prescription history for PAULA PIERCE-SAVOIE PA-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Physician Assistant prescribing approach at this Carterville, IL practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among IL prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.